Rajesh Sachdeva to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Rajesh Sachdeva has written about Randomized Controlled Trials as Topic.
Connection Strength
0.106
-
Bhogal S, Mukherjee D, Bagai J, Truong HT, Panchal HB, Murtaza G, Zaman M, Sachdeva R, Paul TK. Bivalirudin Versus Heparin During Intervention in Acute Coronary Syndrome: A Systematic Review of Randomized Trials. Cardiovasc Hematol Disord Drug Targets. 2020; 20(1):3-15.
Score: 0.042
-
Taha Y, Patel RAG, Bagai J, Sachdeva R, Kumar G, Prasad A, Nathan S, Paul TK. Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Treatment of Unprotected Left Main Stenosis. Curr Cardiol Rep. 2019 03 18; 21(5):27.
Score: 0.040
-
Michael TT, Abdel-karim AR, Papayannis A, Lichtenwalter C, de Lemos JA, Obel O, Addo T, Roesle M, Haagen D, Rangan BV, Saeed B, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger PB, Banerjee S, Brilakis ES. Recurrent cardiovascular events with paclitaxel-eluting versus bare-metal stents in saphenous vein graft lesions: insights from the SOS (Stenting of Saphenous Vein Grafts) trial. J Invasive Cardiol. 2011 Jun; 23(6):216-9.
Score: 0.023